| Cholangiocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 95show all (up to 200) |
|---|
| → investigated in trials for | Gemcitabinesmall molecule 63 trials (23 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 49 trials (20 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 26 trials (19 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 19 trials (6 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 16 trials (9 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall_molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall_molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Cholangiocarcinoma | 7 | Observed | clinicaltrials | graph → |